Department of Radiology Copenhagen University Hospital Herlev
Copenhagen, DK-2730, Denmark
NCT Number: NCT00300547
The purpose of this study is to diagnose possible synchronous carcinomas and polyps with magnetic resonance (MR) colonography in patients booked for operation because of carcinoma in the descending or sigmoid colon, where a preoperative full colonoscopy is not possible. Two days before colonography, patients ingest a 200 ml Barium sulfate solution four times a day, which will render fecal masses "invisible" on the following MR colonography. The study is primarily a feasibility study with altered operative strategy as a secondary end-point. Gold standard is colonoscopy and operation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Copenhagen, DK-2730, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Altered planned surgical procedure if MR colonoscopy reveals synchronous cancer or larger polyps
Time frame: 3
Time frame: 3
Herlev Hospital
Other
Preoperative Assessment for Synchronous Carcinoma or Polyps With MR Colonography in Patients With Obstructing Cancer. A Prospective Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04369053
Adenoma, Colon Cancer
Birmingham, Alabama, United States
View Trial DetailsNCT04160832
Colonic Diseases, Colorectal Neoplasm
Aurora, Colorado, United States
View Trial DetailsNCT00591279
Colon Cancer, Colonic Diseases
New York, United States
View Trial DetailsNCT03442738
Adenoma, Adenoma Detection Rate
Berlin, Germany
View Trial Details